Granisetron is an indazole derivative with antiemetic properties.
As a selective serotonin receptor antagonist, granisetron competitively blocks the action of serotonin at 5-HT3 receptors, resulting in the suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.
| Product Name |
Granisetron Hydrochloride |
| CAS Number |
107007-99-8 |
| Therapeutic Class |
Serotonin (5-HT3) receptor antagonist, Antiemetic |
| Dosage Form |
Solution for Injection, Oral Tablet |
| Availability |
Commercial |
| Regulatory Status |
USDMF, CEP, JDMF, KDMF, CADMF |